Mechanisms of mucosal healing: treating inflammatory bowel disease without immunosuppression?

EJ Villablanca, K Selin, CRH Hedin - Nature Reviews Gastroenterology …, 2022 - nature.com
Almost all currently available treatments for inflammatory bowel disease (IBD) act by
inhibiting inflammation, often blocking specific inflammatory molecules. However, given the …

Human intestinal barrier function in health and disease

J König, J Wells, PD Cani… - Clinical and …, 2016 - journals.lww.com
The gastrointestinal tract consists of an enormous surface area that is optimized to efficiently
absorb nutrients, water, and electrolytes from food. At the same time, it needs to provide a …

Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 2: current management

M Harbord, R Eliakim, D Bettenworth… - Journal of Crohn's …, 2017 - academic.oup.com
11.1. General The treatment strategy for ulcerative colitis [UC] is mainly based on the
severity, distribution [proctitis, left-sided, extensive] 1 and pattern of disease. The latter …

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management

A Dignass, JO Lindsay, A Sturm… - Journal of Crohn's …, 2012 - academic.oup.com
When deciding the appropriate treatment strategy for active ulcerative colitis one should
consider the activity, distribution (proctitis, left-sided, extensive 1), and pattern of disease …

Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation: lessons learned from animal models and human genetics

L Pastorelli, C De Salvo, JR Mercado… - Frontiers in …, 2013 - frontiersin.org
The gut mucosa is constantly challenged by a bombardment of foreign antigens and
environmental microorganisms. As such, the precise regulation of the intestinal barrier …

Defective epithelial barrier function in asthma

C Xiao, SM Puddicombe, S Field, J Haywood… - Journal of Allergy and …, 2011 - Elsevier
BACKGROUND: Asthma is a complex disease involving gene and environment interactions.
Although atopy is a strong predisposing risk factor for asthma, local tissue susceptibilities …

Inflammatory bowel disease: clinical aspects and established and evolving therapies

DC Baumgart, WJ Sandborn - The Lancet, 2007 - thelancet.com
Crohn's disease and ulcerative colitis are two idiopathic inflammatory bowel disorders. In
this paper we discuss the current diagnostic approach, their pathology, natural course, and …

[HTML][HTML] The fundamental basis of inflammatory bowel disease

W Strober, I Fuss, P Mannon - The Journal of clinical …, 2007 - Am Soc Clin Investig
Two broad hypotheses have arisen regarding the fundamental nature of the pathogenesis of
inflammatory bowel diseases (IBDs, which include ulcerative colitis and Crohn disease). The …

A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis

G D'haens, WJ Sandborn, BG Feagan… - …, 2007 - gastrojournal.org
Ulcerative colitis (UC) is a common gastrointestinal disorder in adults. Recent advances in
pathophysiology, immunology, and pharmaceutical science have resulted in a large number …

Expression and function of the epidermal growth factor receptor in physiology and disease

J Chen, F Zeng, SJ Forrester, S Eguchi… - Physiological …, 2016 - journals.physiology.org
The epidermal growth factor receptor (EGFR) is the prototypical member of a family of
membrane-associated intrinsic tyrosine kinase receptors, the ErbB family. EGFR is activated …